|
|
0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
| Navn | Melbye Invest AS |
|---|---|
| Orgnr/født år | 948559676 |
| Ant aksjer | 957 |
| Omsetning | |
| Driftsresultat | |
| Egenkapital | |
| Ant.eiere | 2 |
| Navn | Orgnr/født år | Aksjeklasse | Ant aksjer | Andel |
|---|---|---|---|---|
| Hca Melbye AS | 914245583 | A-aksjer | 900 | 94.0% |
| Melbye Invest AS | 948559676 | B-aksjer | 57 | 6.0% |
| Navn | Via | Ant aksjer | Andel | Egenkapital |
|---|---|---|---|---|
| Høye Nord AS | Hca Melbye AS | 285 | 29.8% | |
| Hca Melbye AS | Hca Melbye AS | 246 | 25.7% | |
| Ekebakken Holding AS | Hca Melbye AS | 236 | 24.7% | |
| På Øverste Hylle AS | Hca Melbye AS | 87 | 9.0% | |
| Hca Melbye AS | Melbye Invest AS | 54 | 5.6% | |
| Hca Melbye Holding AS | Hca Melbye AS | 47 | 4.9% | |
| Melbye Invest AS | Melbye Invest AS | 3 | 0.4% |
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Katapult Accelerator Fund 2 AS | 200,000 | 6.6% | -12 | 1,377 | 22 | |
| Melbye Invest AS | 57 | 6.0% | 2 | |||
| Katapult Seed Fund 1 AS | 10,000 | 1.6% | -9 | 975 | 21 | |
| Imerso AS | 141 | 1.3% | 159 | -107 | 216 | 38 |
| Consigli AS | 116 | 0.8% | 158 | -17 | 242 | 31 |
| Lytix Biopharma AS | 14,490 | 0.0% | 1 | -35 | 19 | 1,097 |
| Amicoat AS | 2,555 | 0.0% | 1 | -0 | 5 | 311 |
| Pharmasum Therapeutics AS | 241 | 0.0% | 0 | -0 | 0 | 683 |
| Pharma Holdings AS | 51 | 0.0% | 0 | -1 | 1 | 291 |
* Justert for eierandel
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Katapult Accelerator Fund 3 AS | 14,262 | 1.0% | -0 | 79 | 17 | |
| Diwala AS | 198 | 0.5% | 1 | -21 | -75 | 6 |
| Katapult Accelerator Fund 2 AS
Via Melbye Invest AS |
11,912 | 0.4% | -1 | 82 | 22 | |
| Melbye Invest AS
Via Melbye Invest AS |
3 | 0.4% | 2 | |||
| Bio-Me AS | 11,619 | 0.3% | 21 | -29 | 8 | 53 |
| Ducky AS | 300 | 0.2% | 16 | 5 | 40 | 22 |
| Farmforce AS | 3,153 | 0.1% | 29 | -27 | 32 | 46 |
| Katapult Seed Fund 1 AS
Via Melbye Invest AS |
596 | 0.1% | -1 | 58 | 21 | |
| Imerso AS
Via Melbye Invest AS |
8 | 0.1% | 9 | -6 | 13 | 38 |
| Zeabuz AS | 569 | 0.1% | 6 | -6 | 12 | 31 |
| Whee! AS | 31 | 0.1% | 3 | -3 | 5 | 45 |
| Consigli AS
Via Melbye Invest AS |
7 | 0.1% | 9 | -1 | 14 | 31 |
| Imerso AS
Via Imerso AS |
4 | 0.0% | 4 | -3 | 5 | 38 |
| Peptide Patents AS
Via Amicoat AS |
0 | 0.0% | 0 | -0 | 0 | 2 |
| Peptide Patents AS | 0 | 0.0% | 0 | -0 | 0 | 2 |
| Lytix Biopharma AS
Via Melbye Invest AS |
863 | 0.0% | 0 | -2 | 1 | 1,097 |
| Amicoat AS
Via Melbye Invest AS |
152 | 0.0% | 0 | -0 | 0 | 311 |
| Pharmasum Therapeutics AS
Via Melbye Invest AS |
14 | 0.0% | 0 | -0 | 0 | 683 |
| Pharma Holdings AS
Via Melbye Invest AS |
3 | 0.0% | 0 | -0 | 0 | 291 |
| Pharmasum Therapeutics AS | 3 | 0.0% | 0 | -0 | 0 | 683 |
* Justert for eierandel
